Previous studies showed the applicability of FABP2 for detection of intestinal injury after acute ischemic diseases, rejection and necrotic enterocolitis [4], [5], whereas FABP2 concentrations in plasma of healthy individuals were reported to be undetectable or very low [5], [29]. The gene discussed is FABP2; the disease is necrotizing enterocolitis.